CD8A and neoplasm: Thrillingly, we observed that the additional adoption of PD-1/PD-L1 blockade therapy inhibited tumor growth even more significantly and induced tumor regression, albeit while noting that it also increased the quantity of intra-tumoral CD8+ T cells.